REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biogenix, S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Testing Laboratories | Management Consulting Services | All Other Schools and Instruction
Full name: Biogenix, S.R.O. Profile Updated: May 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Biogenix, S.R.O. is an enterprise located in Czech Republic, with the main office in Prague. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on April 27, 1993. 1 - 5 (2023) employees currently work for Biogenix, S.R.O.. From the latest financial highlights, Biogenix, S.R.O. reported a net sales revenue increase of 10.77% in 2025. Its total assets grew by 32.59% over the same period. In, 2025, the company’s net profit margin increased by 2.12%.

Headquarters
Kostelecka 879/59
Prague; The City of Prague; Postal Code: 19600

Contact Details: Purchase the Biogenix, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Biogenix, S.R.O. report to view the information.
Registered Capital:
Purchase the Biogenix, S.R.O. report to view the information.
Financial Auditors:
Purchase the Biogenix, S.R.O. report to view the information.
Incorporation Date:
April 27, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Biogenix, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
10.77%▲
Total Operating Revenue
12.24%▲
Operating Profit
24.13%▲
EBITDA
24.13%▲
Net Profit/Loss for the Period
26.54%▲
Total Assets
32.59%▲
Total Equity
25.78%▲
Operating Profit Margin
2.34%▲
Net Profit Margin
2.12%▲
Return on Equity (ROE)
0.59%▲
Quick Ratio
-0.29%▼
Cash Ratio
0.08%▲

Similar companies

Phoenix Lekarensky Velkoobchod, S.R.O.
 
Alliance Healthcare S.R.O.
Zentiva, K.S.
 
Viapharma S.R.O.
Pharmos, A.S.
 
Solvent Cr S.R.O.
Aptos, S.R.O.
 
Aptum, A.S.
Nextporter S.R.O.
 
Diagnostica, S.R.O.
Rougier S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo